Xeris Biopharma Holdings, Inc. (XERS) Revenue History
Xeris Biopharma Holdings, Inc. (XERS) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $49.59M |
| 2022-12-31 | $110.25M |
| 2023-03-31 | $33.20M |
| 2023-06-30 | N/A |
| 2023-12-31 | $163.91M |
| 2024-12-31 | $203.07M |
| 2025-12-31 | $291.85M |
How XERS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| EOLS | Evolus Inc. | $297.18M |
| RIGL | Rigel Pharmaceuticals Inc. | $294.28M |
| VCEL | Vericel Corporation | $276.26M |
| HROW | Harrow Inc Com | $272.30M |
| IOVA | Iovance Biotherapeutics Inc. | $263.50M |
These are five companies in the same sector as XERS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Xeris Biopharma Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("XERS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XERS | $8.48 | -1.40% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 |